Shinva Medical Instrument (600587.SH) Subsidiary's Medical Molecular Sieve Oxygen Generation System Obtained Class II Medical Device Registration Certificate.
Xinhua Medical (600587.SH) announced that its subsidiary Shandong Xinhua Medical Environmental Protection Equipment Co., Ltd. recently received the "Medical Device Registration Certificate of the People's Republic of China" issued by the Shandong Provincial Drug Administration. The product registered this time is a medical molecular sieve oxygen generation system, which is suitable for producing oxygen-enriched air (93% oxygen) through pressure swing adsorption method. This product, as the core equipment of hospital central oxygen supply system, can synergize with existing product lines to enhance overall competitiveness.
Shinva Medical Instrument (600587.SH) announced that its subsidiary Shandong Xinhua Medical Environmental Equipment Co., Ltd. has recently received the "Medical Device Registration Certificate" issued by the Shandong Provincial Drug Administration. The product covered by this registration certificate is a medical molecular sieve oxygen generation system, which is used for producing oxygen-enriched air (93% oxygen) by pressure swing adsorption. This product, as the core equipment of the hospital central oxygen supply system, can work together with the existing product line to enhance overall competitiveness.
Related Articles
CHEVRON (02285) spent approximately HK$228.89 million on repurchasing 150,000 shares on June 10th.
KINGDEE INT'L (00268) spent HKD 7.2 million to repurchase 1 million shares on June 10th.
POU SHENG INT'L (03813) had a net comprehensive operating income of 1.457 billion yuan in May, a year-on-year decrease of 2.7%.
CHEVRON (02285) spent approximately HK$228.89 million on repurchasing 150,000 shares on June 10th.
KINGDEE INT'L (00268) spent HKD 7.2 million to repurchase 1 million shares on June 10th.
POU SHENG INT'L (03813) had a net comprehensive operating income of 1.457 billion yuan in May, a year-on-year decrease of 2.7%.
RECOMMEND
